TBX2 and non-small cell lung carcinoma: Our findings demonstrate that suppression of the TBX2 subfamily occurs early on in human NSCLC pathogenesis and exhibits diagnostic properties of a candidate high-potential biomarker for early detection of lung cancer in high-risk smokers.